ArriVent BioPharma, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
ArriVent BioPharma, Inc.
CIK #0001868279
EDGAR Form CIK 2011 - 2025
10-K [0001868279]
10-Q [0001868279]
3 [0001868279]
4 [0001868279]
8-K [0001868279]
D [0001868279]
SC 13D [0001868279]
SC 13G [0001868279]
Form 13D/13G Filer Form 13D/13G Subject Filed
Infinitum Asset Management LLC Arrivent Biopharma Inc [2025-08-13]
Infinitum Asset Management LLC Arrivent Biopharma Inc [2025-05-15]
Novo Holdings A/S Arrivent Biopharma Inc [2025-02-14]
Suvretta Capital Management LLC Arrivent Biopharma Inc [2024-12-04]
HHLR Advisors Ltd Arrivent Biopharma Inc [2024-11-14]
Sofinnova Venture Partners Xi LP Arrivent Biopharma Inc [2024-11-12]
FMR LLC Arrivent Biopharma Inc [2024-11-12]
BlackRock Inc Arrivent Biopharma Inc [2024-11-08]
BlackRock Inc Arrivent Biopharma Inc [2024-10-24]
Octagon Capital Advisors LP Arrivent Biopharma Inc [2024-10-11]
View All
Form 3/4/5 Subject 2011 - 2025
ArriVent BioPharma, Inc.
LaChapelle Robin
Parsey Merdad
Peterson Kristine
Hohneker John
Nolet Chris
Kastenmayer James Paul
Yao Zhengbin
Lutzker Stuart
Kung Winston
View All
Terms | Privacy | Guide
tony@aum13f.com